Drawing for HEMESEQ

USPTO serial 87173384

HEMESEQ

Reviewed by CopyMark Law Group

Reg. 5525434Status 702Registered
Filing date
Status date
Registration date
Jul 24, 2018
Examiner
SALCIDO, JOHN CHARLES
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with HEMESEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Davis

David J. Davis Baker & McKenzie LLP300 E. Randolph StreetSuite 5000Chicago, IL 60601

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research in the field of cancer treatment and diagnosis featuring molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for scientific and clinical research purposesACTIVEDec 1, 2016
044Medical testing for diagnostic and treatment purposes in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for medical diagnostic and treatment purposesACTIVEDec 1, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 1, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 1, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 1, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 14, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jul 24, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 24, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 15, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 1, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 31, 2018EX2GSOU EXTENSION 2 GRANTED—
May 31, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 8, 2018IUAFUSE AMENDMENT FILED—
May 8, 2018NREVNOTICE OF REVIVAL - E-MAILED—
May 8, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 8, 2018TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 8, 2018PETGPETITION TO REVIVE-GRANTED—
May 8, 2018PROATEAS PETITION TO REVIVE RECEIVED—
May 7, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 7, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 19, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 4, 2018EXT2SOU EXTENSION 2 FILED—
Sep 30, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Sep 28, 2017EX1GSOU EXTENSION 1 GRANTED—
Sep 28, 2017EXT1SOU EXTENSION 1 FILED—
Sep 28, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 4, 2017NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 18, 2017NPUBNOTICE OF PUBLICATION—
Dec 27, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 22, 2016DOCKASSIGNED TO EXAMINER—
Sep 21, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 20, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance